Latest Product Launch News

Nuchev Limited reports a record-breaking Q4 FY25 with revenues soaring 167% year-on-year, driven by strong growth across multiple markets and a strategic agency agreement in Australia.

OMG Group Limited has reported a remarkable 253% increase in quarterly cash receipts for Q4 FY25, driving annual revenues up 63% to $4.13 million and positioning the company for further growth in FY26.

BetMakers Technology Group capped FY25 with its strongest quarterly results ever, showcasing record profitability, positive cash flow, and a debt-free balance sheet. The company’s strategic investments and recent capital raise set the stage for accelerated growth in FY26, including a key acquisition in Nevada.

Tinybeans Group Limited has reported a second straight quarter of positive operating cash flow alongside steady subscriber growth and new product launches, signaling a turning point for the family-focused subscription platform.

Integrated Research reports a softer FY25 with declines in contract value and earnings, yet steady underlying revenue and promising AI-driven product launches signal a strategic pivot.

HUB24 Limited has reported a record $19.8 billion in net inflows for FY25, driven by strong platform growth and significant migrations from Equity Trustees. The company also launched an innovative high net worth solution, reinforcing its market leadership.

Atturra Limited reports FY25 underlying EBITDA exceeding $31 million and revenue topping $300 million, setting the stage for a strong growth outlook in FY26 driven by acquisitions and product expansion.

Compumedics Limited has reported record sales orders and a return to profitability in FY25, setting the stage for robust growth in FY26 driven by US market traction and SaaS expansion.

Artrya Limited has secured a five-year, US$0.6 million contract with Tanner Health, marking its inaugural commercial revenue in the U.S. market for its AI-powered Salix Coronary Anatomy platform.

Botanix Pharmaceuticals reports robust early sales and expanding prescriber engagement for Sofdra™, its FDA-approved topical gel for excessive underarm sweating, signaling promising growth ahead.

Vanguard Investments Australia Limited will forgo half-yearly financial reports for select ETFs in their first short financial year, leveraging ASIC’s regulatory relief to streamline reporting.

Nanosonics has launched trophon3, its next-generation ultrasound disinfection device, alongside a software upgrade for existing users, promising faster cycles and enhanced digital integration.